Price $99.98 |
Market Cap
3.07B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
3.64
|
P/S
2.76
|
Dividend %
0.80%
|
|
P/CF
-
|
P/FCF
42.2
|
Op. Cash Flow
111.8K
|
FCF
2.3
|
|
Op. Margin
10.50%
|
Net Margin
6.00%
|
ROE
8.10%
|
ROI
6.70%
|
|
ROA
3.50%
|
EPS Growth
365.50%
|
Current Ratio
2.3
|
Debt/Equity
85.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| AngioDynamics, Inc. (ANGO) | $23.70 | - | - | 881.1M | Strong Buy |
| CordovaCann Corp (LVRLF) | $0.16 | - | - | 16.9M | Strong Buy |
| Harrow Health Inc (HROW) | $6.65 | - | - | 180.6M | Strong Buy |
| Lannett Company, Inc. (LCI) | $0.59 | - | - | 24.5M | Strong Buy |
| Stoke Therapeutics Inc (STOK) | $19.56 | - | - | 603.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
